For instance, a test measuring serum phosphorylated tau (p-tau) concentrations appears to be as accurate as cerebrospinal fluid biomarkers [65], and may be 90% accurate in identifying AD, compared to a specialist performing a cognitive evaluation or interpreting imaging, which is 63–73% accurate [66]. This evidence concerns the gene MAPT and Alzheimer disease.